Pfizer: Updated COVID-19 Vaccine Data for Children Under 5 Expected by April

Pfizer: Updated COVID-19 Vaccine Data for Children Under 5 Expected by April
Syringes with the Pfizer COVID-19 vaccine to be administered to children from 5-11 years old are seen at the Beaumont Health offices in Southfield, Mich., on Nov. 5, 2021. Jeff Kowalsky/AFP via Getty Images
Zachary Stieber
By Zachary Stieber, Senior Reporter
Updated:

Pfizer has amended its COVID-19 vaccine trial for younger children and expects results in several months, a researcher said Wednesday.

The study has been adjusted from two doses to three doses in light of the growing body of evidence showing the primary regimen’s effects wane as time goes on from vaccination, Dr. Alejandra Gurtman, part of Pfizer’s clinical research and development group, told a panel that advises the Centers for Disease Control and Prevention (CDC) on vaccine policy during a virtual meeting.

Zachary Stieber
Zachary Stieber
Senior Reporter
Zachary Stieber is a senior reporter for The Epoch Times based in Maryland. He covers U.S. and world news. Contact Zachary at [email protected]
twitter
truth
Related Topics